HOME >> MEDICINE >> NEWS
Vitamin supplement use may reduce effects of Alzheimer's disease

d towards reduced Alzheimer's disease with a combination of vitamin E and C supplements, even after controlling for age, sex, education and general health. However, there was no notable reduction in the risk of Alzheimer's disease with vitamin E or vitamin C alone or with multivitamins. Multivitamins typically contain the recommended daily allowance of vitamin E (22 IU or 15 mg) and vitamin C (75-90 mg), while individual supplements contain doses up to 1,000 IU of vitamin E and 500-1,000 mg or more of vitamin C.

The researchers explained that the use of vitamins E and C may offer protection against Alzheimer's disease when taken together in the higher doses available in individual supplements. In addition, there may be some protective effect with vitamin E when it is combined with the lower doses of vitamin C found in multivitamins.

Dr. Zandi said, "Further study with randomized prevention trials is needed before drawing firm conclusions about the protective effects of these antioxidants. Such trials should consider testing a regimen of vitamin E and C in combination. If effective, the use of these antioxidant vitamins may offer an attractive strategy for the prevention of Alzheimer's disease."


'"/>

Contact: Kenna Brigham
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
19-Jan-2004


Page: 1 2

Related medicine news :

1. Vitamin E may not prevent cancer or cardiovascular events, but may increase risk for heart failure
2. Vitamin C reduces level of C-reactive protein, finds UC Berkeley-led study
3. Vitamins good for some older women/bad for others
4. Vitamin B-12 levels linked to bone loss in aging women
5. Vitamins help treat depression
6. Vitamin D deficiency emerges as new epidemic
7. Vitamins C and E improve cardiovascular health in children with high cholesterol, study says
8. Vitamins C and E may enhance effectiveness of insulin for diabetes
9. Vitamins valuable for baby boomers eye disease
10. Vitamin E fails to join heart-health regimen
11. Vitamins C and E support breathing following an operation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the ... Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... to say, he is "panther quick and leather tough." His love for others is ...
(Date:5/26/2017)... ... ... Garden of Eden”: retells the stories of three Bible figures in modern terms. “Just ... mother, trader, horse farmer, artist and a former GM journeyman. Born in 1953 in ... moved to Dayton, Ohio, where Penny graduated high school. At sixteen, she toured France ...
(Date:5/26/2017)... ... May 26, 2017 , ... Water damage to the flooring of several classrooms ... left education officials with a number of critical issues to address before students could ... be accomplished with little or no disruption to class schedules. Second, the project had ...
(Date:5/24/2017)... ... May 24, 2017 , ... In modern research, success depends ... instruments for research and understanding the basic principles that were designed to drive ... innovations in stereo microscopy for brightfield and fluorescence typically used in laboratories working ...
(Date:5/24/2017)... Laguna Hills, CA (PRWEB) , ... May 24, 2017 , ... ... solutions, announced today its participation in nVerge 2017 – a one-day technology conference in ... , Altec’s document management solution, which allows users to fully utilize and enhance their ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... , May 18, 2017  Two Bayer U.S. Pharmaceutical ... (HBA) during its recent 28 th Woman ... The event showcases HBA,s longstanding mission of furthering the ... healthcare. Cindy Powell-Steffen , senior director ... Radiology division, and Libby Howe , a regional ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) ... second quarter ended April 1, 2017 .   GAAP ... compared to the prior year period as the sale ... gain, while non-GAAP diluted EPS of $0.50 increased 6.4%.  ... constant currency terms.  Excluding the effects of blood screening ...
Breaking Medicine Technology:
Cached News: